RadioMedix, Inc.
PrivateLast Round
Series A
Oct 7, 2022
Total Funding Raised
$44M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RadioMedix, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series A round in October 2022.
RadioMedix, Inc. is a biotechnology company that develops and commercializes targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RadioMedix, Inc. Comparables
Compare RadioMedix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ratio Therapeutics Inc. | 77% | |
| AdvanCell | 76% | |
| Aktis Oncology | 76% |
For institutional investors. Book with your work email.
RadioMedix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2022 | ||||
| Grant | Nov 18, 2021 | ||||
| Grant | Jan 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RadioMedix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Portland Investment Counsel Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 102% MoM, reaching 2.6K.
- Jul 17, 2026
Open roles increased to 14, 3.5x the trailing average.
For institutional investors. Book with your work email.
RadioMedix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RadioMedix, Inc.'s valuation, stock price, and market status.
Is RadioMedix, Inc. a public or private company?
RadioMedix, Inc. is a private company.
What is the current stock price of RadioMedix, Inc.?
RadioMedix, Inc. is a private company, so its shares have no public market price. Caplight tracks RadioMedix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RadioMedix, Inc. worth (valuation)?
Valuation information for RadioMedix, Inc. is not publicly available.
Can I buy RadioMedix, Inc. stock?
RadioMedix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RadioMedix, Inc.'s last funding round?
RadioMedix, Inc.'s most recent funding round was Series A on October 7, 2022.
Who are the main investors in RadioMedix, Inc.?
Key investors in RadioMedix, Inc. include Portland Investment Counsel Inc..
Will RadioMedix, Inc. IPO soon?
No public IPO plans have been announced for RadioMedix, Inc..
How can I track RadioMedix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in RadioMedix, Inc.'s shares on secondary markets.